CREDIT SUISSE NEW ISSUE: 6 American Call Warrants on Roche Holding Donnerstag, 25. November 2021 - 09:06
Dear Investor
Please find hereafter the details for these new issues:
Ticker | Valor | ISIN | Underlying | Spot | Strike | Ratio | Maturity | Type | Issue price | Impl. Vola | PDF File |
JROGCS | 11 505 7139 | CH 115 057 139 1 | Roche Holding AG | CHF 360.00 | CHF 340.00 | 50:1 | 16.09.2022 | Call | CHF 0.68 | 21.58% | |
KROGCS | 11 505 7140 | CH 115 057 140 9 | Roche Holding AG | CHF 360.00 | CHF 370.00 | 50:1 | 16.09.2022 | Call | CHF 0.38 | 20.72% | |
LROGCS | 11 505 7141 | CH 115 057 141 7 | Roche Holding AG | CHF 360.00 | CHF 400.00 | 50:1 | 16.09.2022 | Call | CHF 0.21 | 20.82% | |
MROGCS | 11 505 7142 | CH 115 057 142 5 | Roche Holding AG | CHF 360.00 | CHF 340.00 | 50:1 | 16.06.2023 | Call | CHF 0.86 | 22.47% | |
NROGCS | 11 505 7143 | CH 115 057 143 3 | Roche Holding AG | CHF 360.00 | CHF 380.00 | 50:1 | 16.06.2023 | Call | CHF 0.50 | 21.71% | |
OROGCS | 11 505 7144 | CH 115 057 144 1 | Roche Holding AG | CHF 360.00 | CHF 420.00 | 50:1 | 16.06.2023 | Call | CHF 0.29 | 21.73% |
Please visit our website http://www.credit-suisse.com/derivatives to see the complete list of our products.
The warrants will be placed directly in the secondary market. Please call 044/335 76 00.
Kind regards
CREDIT SUISSE AG
Investment Banking
Equity Derivatives & Structured Products
Uetlibergstrasse 231
8070 Zürich, Switzerland
Tel: +41 44 - 335 76 00
Fax: +41 44 - 333 78 08
www.credit-suisse.com
This message may contain confidential, proprietary or legally privileged information and is intended only for the use of the addressee named above. No confidentiality or privilege is waived or lost by any mistransmission. If you are not the intended recipient of this message you are hereby notified that you must not use, disseminate, copy it in any form or take any action in reliance on it. If you have received this message in error please delete it and any copies of it and notify the sender immediately. Credit Suisse Group and its subsidiaries reserve the right to intercept and monitor any e-mail communication through its networks if legally allowed.